Fundraising Fox

Hemovent

acquired by Microport

1 known investors

Hemovent develops the MobyBox, a pneumatically driven extracorporeal membrane oxygenation (ECMO) system, including a low-resistance high-performance oxygenator. The device is used for respiratory and cardiac support, including cases of COVID-19-associated adult respiratory distress syndrome.

HardwareHealthtechMedical Devices

Investors · 1

MIG Capital AGMunich · $1.1M – $10.8M

Frequently asked questions

What does Hemovent do?
Hemovent develops the MobyBox, a pneumatically driven extracorporeal membrane oxygenation (ECMO) system, including a low-resistance high-performance oxygenator. The device is used for respiratory and cardiac support, including cases of COVID-19-associated adult respiratory distress syndrome.
Who are Hemovent's investors?
Hemovent's investors include MIG Capital AG.
Who acquired Hemovent?
Hemovent was acquired by Microport.